MASCOT - Post Marketing Registry (MASCOT)
Multinational Abluminal Sirolimus Coated BiO-Engineered StenT - The MASCOT Post Marketing Registry
Sponsor: Icahn School of Medicine at Mount Sinai
This observational or N/A phase trial investigates Atherosclerosis and Coronary Artery Disease and is currently completed. Icahn School of Medicine at Mount Sinai leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 2 earlier versions
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai
- OrbusNeich
For direct contact, visit the study record on ClinicalTrials.gov .